Richard Beckman is Chief Medical Officer at Adverum Biotechnologies, Inc. (ADVM). They have made 2 open-market trades across 1 company since 2022, most recently 2022-09-19.
CIK 0001908942
1 open-market purchase totalling $8K since 2022, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADVM | 43,333 | $189K |
Shares reported on the most recent Form 4, priced at the 2022-09-21 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.